Conference item
Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 345.5KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00125-018-4693-0
Authors
- Publisher:
- Springer Verlag
- Host title:
- Diabetologia
- Journal:
- Diabetologia More from this journal
- Volume:
- 61
- Issue:
- Supplement 1
- Pages:
- S426
- Series:
- Diabetologia
- Publication date:
- 2018-08-21
- Acceptance date:
- 2018-06-12
- DOI:
- EISSN:
-
1432-0428
- ISSN:
-
0012-186X
- Pubs id:
-
pubs:920841
- UUID:
-
uuid:badcc454-9e61-4d5d-82d1-37c0c4b2f8c2
- Local pid:
-
pubs:920841
- Source identifiers:
-
920841
- Deposit date:
-
2018-10-29
- ARK identifier:
Terms of use
- Copyright holder:
- Springer-Verlag
- Copyright date:
- 2018
- Notes:
- © Springer-Verlag GmbH Germany, part of Springer Nature 2018. This paper was presented at the 54th EASD Annual Meeting of the European Association for the Study of Diabetes, Berlin, Germany, 1 – 5 October 2018. This is the accepted manuscript version of the article. The final version is available online from Springer at: https://doi.org/10.1007/s00125-018-4693-0
If you are the owner of this record, you can report an update to it here: Report update to this record